OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
OKYO Pharma Limited - Ordinary Shares (OKYO)
Company Research
Source: GlobeNewswire
Robert J. Dempsey, MBA, Chief Executive Officer, to present at EyeceleratorRaj Patil, PhD, Chief Scientific Officer, to present at ARVO LONDON and NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced CEO presentation at Eyecelerator and leadership participation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver, Colorado. Upcoming Scientific Conferences: Eyecelerator: May 1, 2026Denver, Colorado Presentation Title: Addressing Unmet Needs in Corneal and Anterior Segment DiseasesPresentation Date/Time: Friday May 1, 2026, 2:10-2:15 PM MDTBreakout: Anterior Segment, Room 401Presenter: Robert J. Dempsey, Chief Executive Officer at OKYO PharmaModerators: Julie Schallhorn, MD, MS; Kuldev Singh, MD ARVO Annual Meeting: May 3-7, 2026Denve
Show less
Read more
Impact Snapshot
Event Time:
OKYO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OKYO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OKYO alerts
High impacting OKYO Pharma Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
OKYO
News
- OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual MeetingGlobeNewswire
- OKYO Pharma Announces Director Acquires Shares [Yahoo! Finance]Yahoo! Finance
- OKYO Pharma Announces Chairman and Founder Acquires SharesGlobeNewswire
- OKYO Pharma Announces Director Acquires SharesGlobeNewswire
- OKYO Pharma Announces Chief Development Officer and Director Acquires SharesGlobeNewswire
OKYO
Analyst Actions
- 1/29/26 - HC Wainwright
OKYO
Sec Filings
- 4/29/26 - Form 6-K
- 4/7/26 - Form 6-K
- 3/19/26 - Form 6-K
- OKYO's page on the SEC website